By Fineline Cube 
Lynmou Medical, a Hangzhou-based provider of soft endoscope solutions, has reportedly secured “tens of millions” of renminbi in a Series A financing round. Led by UnityVentures, with participation from CS Capital and returning investor HaiBang Venture, the proceeds will accelerate the company’s commercialization in China and international markets, as well as enhance academic promotion and expand its endoscopic product portfolio.
Company Background
Founded in 2021, Lynmou Medical has established itself as a notable player in the medical technology sector. The company’s Alioth electronic endoscope franchise, recognized for its innovative Deep Hemodynamic Imaging (DHI) technology, received marketing approval in China in May of the previous year. This technology represents a significant advancement in the field of endoscopy, offering improved diagnostic capabilities through advanced imaging techniques.
Funding Utilization
The fresh capital injection will be strategically allocated to drive the company’s growth. Key focus areas include scaling up commercial operations both domestically and in overseas markets, strengthening academic collaborations to promote the adoption of its technologies, and investing in the research and development of its endoscopic product line to maintain a competitive edge in the industry.-Fineline Info & Tech